Clinical Trial Update: Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02) [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial (FOCUS-02) evaluating adjuvant chemotherapy in combination with camrelizumab for stage III gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Yu jiren | Conditions: Gastric Cancer Stage III | Phase 2 | Status: ACTIVE_NOT_RECRUITING